According to Mordor Intelligence, theglobalbiosensors marketis valued at USD 28.50 billion in 2025 and is projected to surpass USD 42.20 billion by 2030 reflecting an 8.17% CAGR, supported by technological advancements in diagnostic toolsandincreased adoption of wearable health devices. The market is furtherbenefitingfrom the convergence of biotechnology, nanotechnology, and electronics, enabling faster, miniaturized, and more sensitive biosensing systems across healthcare, food safety, and environmental monitoring sectors.
https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg
The ongoing digital transformation in diagnostics, alongside growing awareness of preventive health management, continues to elevate biosensors as essential components of next-generation medical and analytical devices.
KeyMarket Insights
Rise inPoint-of-Careand Home-Based TestingThe growing need for accessible, real-time diagnostics has accelerated the deployment of biosensors in portable and home-based testing devices. Patients and clinicians are increasingly relying on point-of-care systems that deliveraccurateresults within minutes, particularly for chronic conditions like diabetes and cardiovascular diseases. This shift is reshaping diagnostic delivery models and boosting adoption among both healthcare providers and consumers.
Growing Adoption Across Non-Medical ApplicationsBeyond healthcare, biosensors are finding increasing use in food safety, environmental analysis, and bioprocess monitoring. Industries are adoptingbiosensor-based systems for detecting contaminants, monitoring pollutants, and ensuring regulatory compliance. This cross-sector expansion broadens the commercial potential of the biosensors market, diversifying revenue streams for manufacturers and technology developers.
Regional MarketOutlook
North Americacontinues to dominate the global biosensors market, driven by a mature healthcare ecosystem, high R&D investment, and strong demand for advanced diagnostic technologies. The United States leads the region with widespread integration of biosensors in medical devices and digital health systems.
Asia-Pacificis projected toexhibitthe fastest growth through 2030, supported by expanding healthcare infrastructure, increasing prevalence of chronic diseases, and a growing base of tech-driven medical device startups. Government initiatives promoting healthcare innovation in China, Japan, and India are further catalyzing regional adoption.
Market Segment Breakdown
By Product Type
— Wearable Biosensors
— Non-wearableBiosensors
By Technology
— Electrochemical
— Optical
— Piezoelectric
— Thermal
— Nanomechanical
By Application
— Medical
— Glucose
— Cholesterol
— Pregnancy
— Infectious Disease
— Food Toxicity Testing
— Environmental Monitoring
— Agriculture
— Bioreactor Monitoring
— Other Product Types
By End User
— Point-of-Care Testing
— Home Healthcare Diagnostics
— Research Laboratories
— Food and Beverage Industry
— Security andBiodefense
— Biodefense
By Geography
— North America
— Europe
— Asia-Pacific
— Middle East & Africa
— South America
For a full breakdown of market size, segmentation data, and competitive intelligence, access the details of the Mordor Intelligence report:https://www.mordorintelligence.com/industry-reports/biosensors-market?utm_source=prnewswire
Strategic Competitive Environment
Thebiosensors marketis moderately fragmented, with global players investing in advanced sensing technologies, miniaturization, and wireless data integration. Partnerships between biosensor manufacturers, diagnostics companies, and tech innovators are driving new product launches and expanding application diversity. Strategic collaborations and acquisitionsremainkey approaches to enhance market share and access emerging healthcare segments.
Key Companies Include:
— Abbott Laboratories
— Medtronic Plc
— Dexcom, Inc.
— SenseonicsHoldings Inc.
— i-SENS Inc.
Check out related reports published by Mordor Intelligence:
Coronary Stent Market:Thecoronary stents market is segmented by product type (drug eluting stent, bare metal coronary stent), biomaterial (metallic, polymeric), mode of delivery (balloon-expandable stent and self-expanding stent), end user (hospitals, ambulatory surgical centers), and geography(North America, Europe, Asia-Pacific, and More).
Therapeutic Drug Monitoring Market:Thetherapeutic drug monitoring market is segmented by technology (immunoassays, proteomic), drug class (antiarrhythmic drugs, immunosuppressants), end-user (hospital laboratories, independent / reference laboratories), and geography.
ThermoFisher Scientific, Bio-Rad Laboratories, F. Hoffmann-La Roche Ltd, Danaher Corporation (Beckman Coulter, Inc.)and Siemens Healthcare GmbHare the major companiesoperatingin this market.
Read more about companies active inTherapeutic Drug Monitoring:https://www.mordorintelligence.com/industry-reports/therapeutic-drug-monitoring-market/companies?utm_source=prnewswire
About MordorIntelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries,Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries, please contact:media@mordorintelligence.com
https://www.mordorintelligence.com/contact-us
Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg
https://edge.prnewswire.com/c/img/favicon.png?sn=IO27316&sd=2025-11-18
View original content:https://www.prnewswire.com/news-releases/biosensors-market-dominated-by-electrochemical-sensors-with-72-revenue-share-as-global-biosensors-market-size-is-set-to-surpass-usd-42b-by-2030-says-mordor-intelligence-302618373.html
SOURCE Mordor Intelligence Private Limited
https://rt.newswire.ca/rt.gif?NewsItemId=IO27316&Transmission_Id=202511180516PR_NEWS_USPR_____IO27316&DateId=20251118